Cyclacel Pharmaceuticals (NASDAQ:CYCC) Now Covered by Analysts at StockNews.com
by The Cerbat Gem
The Cerbat Gem— Analysts at StockNews.com began coverage on shares of Cyclacel Pharmaceuticals (NASDAQ:CYCC – Get Free Report) in a report released on Tuesday. The brokerage set a “hold” rating on the biotechnology company’s stock. Several other research analysts also recently commented on the stock. Brookline Capital Management downgraded shares of Cyclacel Pharmaceuticals from a “buy” rating to […]
The Cerbat Gem—Haynes International (NASDAQ:HAYN) Now Covered by Analysts at StockNews.com. StockNews.com started coverage on shares of Haynes International (NASDAQ:HAYN – Free Report) in a research report released on Saturday. The firm issued a hold rating on the basic materials company’s stock. HAYN has been the topic of a number of other reports. Noble Financial lowered Haynes International from an outperform rating to a market perform […]
The Cerbat Gem—Taro Pharmaceutical Industries (NYSE:TARO) Now Covered by Analysts at StockNews.com. StockNews.com started coverage on shares of Taro Pharmaceutical Industries (NYSE:TARO – Free Report) in a report published on Saturday. The firm issued a strong-buy rating on the stock. Separately, HC Wainwright lowered Taro Pharmaceutical Industries from a buy rating to a neutral rating and set a $43.00 price objective for the company. in a research […]
The Cerbat Gem—Carrols Restaurant Group (NASDAQ:TAST) Now Covered by Analysts at StockNews.com. StockNews.com assumed coverage on shares of Carrols Restaurant Group (NASDAQ:TAST – Free Report) in a research report sent to investors on Tuesday morning. The firm issued a buy rating on the restaurant operator’s stock. A number of other research firms have also recently weighed in on TAST. Truist Financial reiterated a hold rating and set […]